Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Immunotherapy and RIT in Head-and-Neck SCC

VIEWS: 6 PAGES: 1

In an article e-published on March 9 ahead of print in Clinical Cancer Research, Niu and a consortium of colleagues from the National Institutes of Health (Bethesda, MD), Harbin Medical University (China), and the Stanford University School of Medicine (CA) reported on a study designed to show the relationship between antibody delivery and therapeutic efficacy in head and neck squamous cell carcinoma (SCC) by evaluating the pharmacokinetics and pharmacodynamics of epidermal growth factor receptor (EGFR )-targeted immunotherapy and radioimmunotherapy by quantitative PET imaging.

More Info
To top